Lung Cancer
News
Nearly 30% of U.S. cancer deaths linked to smoking
Getting more people to screen for lung cancer in the United States is also important, given that only 6.6% of eligible people in 2019 received...
Clinical Review
Safety Profile of Mutant EGFR-TK Inhibitors in Advanced Non–Small Cell Lung Cancer: A Meta-analysis
This meta-analysis showed that mutant epidermal growth factor receptor–tyrosine kinase inhibitors have an incidence of adverse effects that is...
Conference Coverage
A look at lung cancer screening in resource-limited countries
Interim report from IASLC highlights unique challenges faced by low- and middle-income countries.
News
FDA approves Enhertu (trastuzumab deruxtecan) for HER2 lung cancer
“These results establish the new standard of care for patients with NSCLC harboring HER2 mutations.”
Conference Coverage
Air pollution contribution to lung cancer may be underestimated
A study of women with lung cancer who never smoked suggests that air pollution may be a larger risk factor for lung cancer than currently...
Conference Coverage
Smoking cessation with lung screening ups quit rates
Offering smoking cessation support at the time and place of lung cancer screening resulted in high smoking abstinence rates at 1 year.
News
One in four NSCLC patients respond poorly to COVID-19 vaccine
The reasons are unclear, but point to the need for NSCLC patients to have titers checked.
News
Lung cancer treatment combo may be effective after ICI failure
Phase 2 trial offers hope of a chemotherapy-free option for patients with advanced NSCLC.
Conference Coverage
The shifting sands of lung cancer screening
Studies find encouraging trends of stage shifting and minority screening, but more work remains.
News
New KRAS inhibitor shows promise in NSCLC
One out of three lung cancer patients previously treated with chemotherapy and immune therapy responded to a new targeted therapy.